Hirofumi Arakawa

7.4k total citations · 2 hit papers
68 papers, 6.0k citations indexed

About

Hirofumi Arakawa is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hirofumi Arakawa has authored 68 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 41 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Hirofumi Arakawa's work include Cancer-related Molecular Pathways (31 papers), Cancer Research and Treatments (13 papers) and Mitochondrial Function and Pathology (10 papers). Hirofumi Arakawa is often cited by papers focused on Cancer-related Molecular Pathways (31 papers), Cancer Research and Treatments (13 papers) and Mitochondrial Function and Pathology (10 papers). Hirofumi Arakawa collaborates with scholars based in Japan, United Kingdom and United States. Hirofumi Arakawa's co-authors include Koichi Matsuda, Seisuke Fukuda, Yoichi Taya, Toshiki Mori, Chizu Tanikawa, Yusuke Nakamura, Tomoaki Tanaka, Yusuke Nakamura, Tatsuya Yamaguchi and Kenji Shiraishi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Hirofumi Arakawa

67 papers receiving 5.8k citations

Hit Papers

p53AIP1, a Potential Mediator of p53-Dependent Apoptosis,... 2000 2026 2008 2017 2000 2000 250 500 750

Peers

Hirofumi Arakawa
Bruce Ruggeri United States
Lindsey D. Mayo United States
France Carrier United States
Alexander Zaika United States
Vivek M. Rangnekar United States
JC Reed United States
Arthur Sands United States
Oleksi Petrenko United States
Xinbin Chen United States
Yoon S. Cho‐Chung United States
Bruce Ruggeri United States
Hirofumi Arakawa
Citations per year, relative to Hirofumi Arakawa Hirofumi Arakawa (= 1×) peers Bruce Ruggeri

Countries citing papers authored by Hirofumi Arakawa

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Arakawa more than expected).

Fields of papers citing papers by Hirofumi Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Arakawa. The network helps show where Hirofumi Arakawa may publish in the future.

Co-authorship network of co-authors of Hirofumi Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Arakawa. A scholar is included among the top collaborators of Hirofumi Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Arakawa. Hirofumi Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oshiro, Aya, Kiyoto Kurima, Shinichiro Kina, et al.. (2025). Association between Kaposi’s sarcoma-associated herpesvirus genotype and clinical types. Pathology & Oncology Research. 31. 1612009–1612009.
2.
Futamura, Manabu, Hiroki Kamino, Yasuyuki Nakamura, et al.. (2020). p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers. Biochemical and Biophysical Research Communications. 529(3). 582–589. 12 indexed citations
3.
Miyamoto, Yuji, Noriaki Kitamura, Yasuyuki Nakamura, et al.. (2011). Possible Existence of Lysosome-Like Organella within Mitochondria and Its Role in Mitochondrial Quality Control. PLoS ONE. 6(1). e16054–e16054. 66 indexed citations
4.
Tanikawa, Chizu, Yoichi Furukawa, Naoko Yoshida, et al.. (2009). XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway. Oncogene. 28(34). 3081–3092. 55 indexed citations
5.
Kamino, Hiroki, Manabu Futamura, Yasuyuki Nakamura, et al.. (2008). B‐cell linker protein prevents aneuploidy by inhibiting cytokinesis. Cancer Science. 99(12). 2444–2454. 9 indexed citations
6.
Futamura, Manabu, Hiroki Kamino, Yuji Miyamoto, et al.. (2007). Possible Role of Semaphorin 3F, a Candidate Tumor Suppressor Gene at 3p21.3, in p53-Regulated Tumor Angiogenesis Suppression. Cancer Research. 67(4). 1451–1460. 82 indexed citations
7.
Minai, Limor, Valérie Serre, Jean-Philippe Jaı̈s, et al.. (2007). Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nature Genetics. 39(6). 776–780. 428 indexed citations
8.
Nakamura, Yasuyuki, Manabu Futamura, Hiroki Kamino, et al.. (2006). Identification of p53–46F as a super p53 with an enhanced ability to induce p53‐dependent apoptosis. Cancer Science. 97(7). 633–641. 25 indexed citations
9.
Masuda, Yoshiko, Manabu Futamura, Hiroki Kamino, et al.. (2006). The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. Journal of Human Genetics. 51(8). 652–664. 111 indexed citations
10.
Arakawa, Hirofumi. (2005). p53, apoptosis and axon-guidance molecules. Cell Death and Differentiation. 12(8). 1057–1065. 73 indexed citations
11.
Yoshida, Koji, Morito Monden, Yusuke Nakamura, & Hirofumi Arakawa. (2004). Adenovirus‐mediated p53AIP1 gene transfer as a new strategy for treatment of p53‐resistant tumors. Cancer Science. 95(1). 91–97. 15 indexed citations
12.
Graff, Pål, Øystein Åmellem, Hirofumi Arakawa, et al.. (2004). Counteraction of pRb‐dependent protection after extreme hypoxia by elevated ribonucleotide reductase. Cell Proliferation. 37(5). 367–383. 6 indexed citations
13.
Ng, Ching Ching, Hirofumi Arakawa, Seisuke Fukuda, Hisato Kondoh, & Yusuke Nakamura. (2003). p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene. 22(28). 4449–4458. 47 indexed citations
14.
Tanikawa, Chizu, Koichi Matsuda, Seisuke Fukuda, Yusuke Nakamura, & Hirofumi Arakawa. (2003). p53RDL1 regulates p53-dependent apoptosis. Nature Cell Biology. 5(3). 216–223. 144 indexed citations
15.
Mori, Toshiki, et al.. (2002). Cyclin K as a Direct Transcriptional Target of the p53 Tumor Suppressor. Neoplasia. 4(3). 268–274. 39 indexed citations
16.
Sasaki, Shin, Tatsuya Nakamura, Hirofumi Arakawa, et al.. (2002). Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene. 21(32). 5024–5030. 25 indexed citations
17.
Okamura, Shu, Hirofumi Arakawa, Tomoaki Tanaka, et al.. (2001). p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis. Molecular Cell. 8(1). 85–94. 290 indexed citations
18.
Oda, Katsutoshi, Hirofumi Arakawa, Tomoaki Tanaka, et al.. (2000). p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53. Cell. 102(6). 849–862. 977 indexed citations breakdown →
19.
Arakawa, Hirofumi, et al.. (1994). Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Human Molecular Genetics. 3(4). 565–568. 90 indexed citations
20.
Sakamoto, Kiyoshi, Hirofumi Arakawa, Seiji Mita, et al.. (1992). Factors Influencing the Increase of Serum IL-6 Concentration in Surgical Patients.. The Japanese Journal of Gastroenterological Surgery. 25(10). 2590–2594. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026